Literature DB >> 17018728

Concurrent chemoradiation for locally advanced carcinoma of the cervix: where are we in 2006?

P G Rose1.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 17018728     DOI： 10.1093/annonc/mdl264

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  9 in total

1.  Combination treatment with dihydrotanshinone I and irradiation enhances apoptotic effects in human cervical cancer by HPV E6 down-regulation and caspases activation.

Authors:  Yintao Ye; Wenqing Xu; Wei Zhong; Yajing Li; Chen Wang
Journal:  Mol Cell Biochem       Date:  2011-12-07       Impact factor: 3.396

2.  Prospective randomized study comparing concomitant chemoradiotherapy using weekly cisplatin & paclitaxel versus weekly cisplatin in locally advanced carcinoma cervix.

Authors:  Pragyat Thakur; Rajeev Seam; Manoj Gupta; Manish Gupta
Journal:  Ann Transl Med       Date:  2016-02

3.  A phase II randomized trial comparing radiotherapy with concurrent weekly cisplatin or weekly paclitaxel in patients with advanced cervical cancer.

Authors:  Fady B Geara; Ali Shamseddine; Ali Khalil; Mirna Abboud; Maya Charafeddine; Muhieddine Seoud
Journal:  Radiat Oncol       Date:  2010-09-23       Impact factor: 3.481

Review 4.  Immunotherapy for human papillomavirus-associated disease and cervical cancer: review of clinical and translational research.

Authors:  Sung Jong Lee; Andrew Yang; T C Wu; Chien Fu Hung
Journal:  J Gynecol Oncol       Date:  2016-05-31       Impact factor: 4.401

5.  Concurrent paclitaxel/cisplatin chemoradiotherapy with or without consolidation chemotherapy in high-risk early-stage cervical cancer patients following radical hysterectomy: preliminary results of a phase III randomized study.

Authors:  Hongqin Zhao; Lili Li; Huafang Su; Baochai Lin; Xuebang Zhang; Shengliu Xue; Zhenghua Fei; Lihao Zhao; Qintuo Pan; Xiance Jin; Congying Xie
Journal:  Oncotarget       Date:  2016-10-25

6.  Decreased Expression of Karyopherin-α 1 is Related to the Malignant Degree of Cervical Cancer and is Critical for the Proliferation of Hela Cells.

Authors:  Lucen Jiang; Dan Li; Chao Wang; Jia Liao; Jianghuan Liu; Qingzhu Wei; Yiyang Wang
Journal:  Pathol Oncol Res       Date:  2022-08-04       Impact factor: 2.874

7.  Novel approaches for concurrent irradiation in locally advanced cervical cancer: platinum combinations, non-platinum-containing regimens, and molecular targeted agents.

Authors:  Giannis Mountzios; Aspasia Soultati; Dimitrios Pectasides; Meletios A Dimopoulos; Christos A Papadimitriou
Journal:  Obstet Gynecol Int       Date:  2013-05-21

8.  Human papillomavirus genotype and prognosis of cervical cancer: Favorable survival of patients with HPV16-positive tumors.

Authors:  Mamiko Onuki; Koji Matsumoto; Yuri Tenjimbayashi; Nobutaka Tasaka; Azusa Akiyama; Manabu Sakurai; Takeo Minaguchi; Akinori Oki; Toyomi Satoh; Hiroyuki Yoshikawa
Journal:  Papillomavirus Res       Date:  2018-10-19

9.  Anti-Tumor Effects of Wee1 Kinase Inhibitor with Radiotherapy in Human Cervical Cancer.

Authors:  Yoo-Young Lee; Young-Jae Cho; Sung-Won Shin; Changhoon Choi; Ji-Yoon Ryu; Hye-Kyung Jeon; Jung-Joo Choi; Jae Ryoung Hwang; Chel Hun Choi; Tae-Joong Kim; Byoung- Gie Kim; Duk-Soo Bae; Won Park; Jeong-Won Lee
Journal:  Sci Rep       Date:  2019-10-28       Impact factor: 4.379
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.